VVUS: VIVUS INC. (NASDAQ) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Mark A. Stang who wrote (13694)	8/20/1998 11:48:00 AM
From: VLAD	Read Replies (1) of 23519

Mark, It is my understanding that Vivus is currently negotiating with more than one potential domestic partner with JNJ as the most likely candidate since they already have an existing relationship with Janssen. Vivus' official line thus far has been to claim that their goal is to get a partner by years end and hopefully sooner. They also say they would "consider" any buy out proposals. IMO JNJ is probably working on a partnership agreement with a contingent for a buy out based on future sales of MUSE. If such a deal occurs it will be a "win win" situation for both companies. JNJ actually gets to see how well MUSE sells in Viagras' presence and with good marketing. Vivus gets a large milestone payment to relieve its cash problem. MUSE sales then speak for themselves and not for Vivus' lack of marketing abilities. The success of the company will then be contingent on the product and not management. The only thing vivus will have to do is to produce MUSE and continue funding Alibra phase III trials.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next